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Dosage compensation: roX marks the spot
John C. Lucchesi
The roX genes of Drosophila produce a transcript that is
spliced and polyadenylated but not translated. Recent
work has shown that these genes provide an element
that the dosage compensation complex of Drosophila
uses to initiate its association with the X chromosome.
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In mammals, dosage compensation — the equalization of
the levels of X-linked gene products between females,
which have two X chromosomes, and males, which have a
single X — is achieved by inactivating one of the two
X chromosomes, early during development, in the somatic
cells of females. The situation in Drosophila is quite differ-
ent, in that both X chromosomes are active, simultane-
ously, in the somatic cells of females. In this group of
organisms, dosage compensation is achieved by a regula-
tory mechanism that doubles the rate of transcription of
most X-linked genes in males. Recent studies have pro-
vided intriguing new insights into the mechanism by
which gene expression from one entire, specific chromo-
some is globally up-regulated.
Over the years, genetic screens and phenotypic-product
assays have led to the identification of five positive regula-
tors of dosage compensation in Drosophila (reviewed in [1]).
These regulators, collectively referred to as male-specific
lethal (MSL) proteins, form a multi-subunit complex
that associates at numerous sites exclusively along the X
chromosome in males. As a consequence of this associa-
tion, a particular isoform of histone H4, acetylated at
lysine 16, is preferentially found along this chromosome
(reviewed in [2]). In females, the MSL complex fails to
assemble because the transcript encoding one of its com-
ponents, MSL2, is not translated. Ectopic expression in
females of an msl-2 cDNA lacking the translational
repression sites leads to the formation of the MSL
complex and to a concomitant loss of viability that
results, presumably, from the hypertranscription of both
X chromosomes [3,4].
How the MSL complex targets the X chromosome and
becomes associated with its sites of action on X chromatin
in males or in transgenic females has long been a mystery.
An important clue was recently provided by Kelley et al. [5],
who succeeded in inducing the ectopic association and
spreading of the MSL complex by transducing either one
of the two known ‘RNA on the X’ (roX) genes to autosomal
sites. These two X-linked genes normally produce non-
translated transcripts in both sexes, but their accumulation
depends on the integrity of the MSL complex. The roX
transcripts are therefore found only in males or in
transgenic females that have been induced to form an
MSL complex [6,7]. In these individuals, the roX RNAs
associate with the X chromosome [6,7] with a distribution
that mirrors that of the MSL complex [8]. As the simulta-
neous deletion of the roX1 and roX2 genes results in the
absence of any visible complex in male embryos [8], these
two RNAs must be the major, if not the only, RNAs asso-
ciated with complex formation.
By exploiting the polytene chromosomes of Drosophila
salivary gland cells, and using indirect immunofluores-
cence microscopy, Kelley et al. [5] observed that the MSL
proteins bound to roX1 or roX2 transgenes located on an
autosome. Remarkably, some nuclei were seen to exhibit
multiple fluorescent bands on either side of the roX1
gene, indicating that the MSL complex had spread from
the transgene locus to autosomal regions where it is not
found normally. In heterozygous larvae, where just one of
the two homologous autosomes carries a roX1 transgene,
spreading was found to occur in trans along the paired
homologue, although to a less extent than on the roX-
bearing chromosome. Both roX1 and roX2 RNAs were
present in the adventitious bands surrounding the roX1
transgene, consistent with the observation that these
RNAs are not limited to the vicinity of the locus from
which they are transcribed.
Insights into the targeting of the MSL complex to the
X chromosome have been gained through studies with
incomplete or inactive forms of the complex. When any
one of the MSL proteins — MSL3, MLE or MOF — was
missing, or the ATP-dependent RNA helicase activity of
MLE or the histone acetyl transferase activity of MOF was
abolished by mutation, the remaining MSL1 and MSL2
subunits were seen to bind to a small subset of complex-
binding sites along the X chromosome (reviewed in [9]).
These 30–40 sites, identified by indirect immunofluores-
cence detection of MSL1 or MSL2 antisera on polytene
chromosomes, are thought to represent points of entry or
assembly for the MSL complex [10]. Interestingly, cyto-
logical mapping showed that the roX1 and roX2 genes
themselves reside within two of these sites.
On the basis of these observations and their recent
findings with roX transgenes, Kelley et al. [5] propose the
following model (Figure 1). The MSL proteins enter the
X chromosome at specific entry sites and, at least at the
two of those sites where the roX genes are located, they
form complexes that incorporate roX RNA. These mature
complexes can then associate with any of the other entry
sites, from where they spread into neighboring regions
along the chromosome. Movement of complexes between
entry sites would explain the fact that roX1 and roX2
RNAs are found at the same sites.
Do the roX RNAs play a role in attracting the complex to
the X chromosome, or are they simply an integral subunit
of the complex that must be available during its assem-
bly? Binding of the MSL complex to a partially deleted
and inactive roX1 transgene [5] would suggest that it
recognizes some feature of the sequence in the RNA or,
in the case of a truncated transgene that is not tran-
scribed, in the DNA antisense strand, and would argue in
favor of the first alternative. The ability of the MSL
complex to access all of the entry sites, whether they
contain a roX gene or not, would argue in favor of the
second alternative.
Binding to a truncated roX1 transgene that is not transcribed
may not reflect the recognition by the MSL complex of
the RNA-encoding DNA sequence, but rather may be
the result of an effect of roX DNA on the local chromatin
configuration, creating an entry site analogous to the one
where the roX gene is normally located. Some characteris-
tic inherent to the roX genes and to a few other
sequences present along the X chromosome may, for
example, cause a sequence-directed positioning of nucle-
osomes that enables the MSL complex to enter chro-
matin. From these sites, the complex may spread by the
epigenetic modification of neighboring nucleosomes.
Irrespective of these considerations, the new results show
that, rather than binding at once all along the X chromo-
some, the MSL complex initially gains access at a limited
number of entry points, from where it then spreads to all
of its sites of action.
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Figure 1
A model for the association of the MSL
complex with the X chromosome in
Drosophila. (a) The MSL proteins (colored
shapes) make unproductive contacts with the
X chromosome at a few sites, so-called entry
sites. Two of these sites contain the roX
genes and here, the MSLs are able to form
complexes that contain roX RNA (red).
(b) Complete complexes access the
X chromosome at the entry sites and
acetylate neighboring nucleosomes
(indicated in light green). (c) Histone
acetylation opens the chromatin to additional
complexes initiating and implementing their
spreading along the X chromosome.
(Adapted from [5].)
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